Market research
APYX Apyx Medical Inc
NASDAQ USD Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 105M
- P/E ratio
- Not available
- Analyst target
- 6.5
- Dividend yield
- Not available
- Beta
- 1.45
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 105M
- P/E ratio
- Not available
- Analyst target
- 6.5
- Dividend yield
- Not available
- Beta
- 1.45
About
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Research context
Apyx Medical Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the APYX discussion.
5 years, 6 months ago
Apyx Medical Corporation is currently in a long term uptrend where the price is trading 8.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Apyx Medical Corporation's total revenue rose by 35.5% to $11M since the same quarter in the previous year.
Its net income has increased by 100.0% to $-2K since the same quarter in the previous year.
Finally, its free cash flow grew by 61.0% to $-1M since the same quarter in the previous year.
Based on the above factors, Apyx Medical Corporation gets an overall score of 5/5.